Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

A short review of experimental peritoneal sclerosis: from mice to men.

Gotloib L, Wajsbrot V, Shostak A.

Int J Artif Organs. 2005 Feb;28(2):97-104. Review.

PMID:
15770597
2.

Acute oxidative stress induces peritoneal hyperpermeability, mesothelial loss, and fibrosis.

Gotloib L, Wajsbrot V, Cuperman Y, Shostak A.

J Lab Clin Med. 2004 Jan;143(1):31-40.

PMID:
14749683
3.

PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.

Sandoval P, Loureiro J, González-Mateo G, Pérez-Lozano ML, Maldonado-Rodríguez A, Sánchez-Tomero JA, Mendoza L, Santamaría B, Ortiz A, Ruíz-Ortega M, Selgas R, Martín P, Sánchez-Madrid F, Aguilera A, López-Cabrera M.

Lab Invest. 2010 Oct;90(10):1517-32. doi: 10.1038/labinvest.2010.111. Epub 2010 Jun 7.

4.

Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?

Bozkurt D, Hur E, Ulkuden B, Sezak M, Nar H, Purclutepe O, Sen S, Duman S.

Perit Dial Int. 2009 Feb;29 Suppl 2:S202-5.

PMID:
19270218
5.

Pathogenesis of peritoneal sclerosis.

Pollock C.

Int J Artif Organs. 2005 Feb;28(2):90-6. Review.

PMID:
15770596
6.

Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.

Zareie M, Hekking LH, Welten AG, Driesprong BA, Schadee-Eestermans IL, Faict D, Leyssens A, Schalkwijk CG, Beelen RH, ter Wee PM, van den Born J.

Nephrol Dial Transplant. 2003 Dec;18(12):2629-37.

PMID:
14605288
7.

Strategies to reduce glucose exposure in peritoneal dialysis patients.

Holmes CJ, Shockley TR.

Perit Dial Int. 2000;20 Suppl 2:S37-41. Review.

PMID:
10911641
8.

Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.

Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S.

Nephrol Dial Transplant. 1999 Jun;14(6):1541-9.

PMID:
10383022
9.

Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.

Fusshoeller A.

Pediatr Nephrol. 2008 Jan;23(1):19-25. Epub 2007 Jul 19. Review.

PMID:
17638023
10.

Theoretical morphological approach to simple peritoneal sclerosis.

Di Paolo N, Gaggiotti E.

Int J Artif Organs. 2005 Feb;28(2):85-9. Review.

PMID:
15770595
11.

Mediators of inflammation and fibrosis.

Lai KN, Tang SC, Leung JC.

Perit Dial Int. 2007 Jun;27 Suppl 2:S65-71. Review.

PMID:
17556333
12.

Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis.

Kanjanabuch T, Siribamrungwong M, Khunprakant R, Kanjanabuch S, Jeungsmarn P, Achavanuntakul B, Pongpirul K, Park MS, Tungsanga K, Eiam-Ong S.

Perit Dial Int. 2008 Jun;28 Suppl 3:S107-13.

PMID:
18552238
13.

Osmotic agents hamper mesothelial repopulation as seen in the doughnut in vivo model.

Gotloib L, Wajsbrot V, Shostak A.

Perit Dial Int. 2005 Feb;25 Suppl 3:S26-30.

PMID:
16048251
14.

Repopulation of the mesothelial monolayer during long-term experimental peritoneal dialysis.

Gotloib L, Wajsbrot V, Shostak A, Khrizman V.

Contrib Nephrol. 2006;150:54-61.

PMID:
16720992
15.

Mechanisms of cell death during peritoneal dialysis. A role for osmotic and oxidative stress.

Gotloib L.

Contrib Nephrol. 2009;163:35-44. doi: 10.1159/000223778. Epub 2009 Jun 3.

PMID:
19494593
16.

Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.

Higuchi C, Nishimura H, Sanaka T.

Ther Apher Dial. 2006 Aug;10(4):372-9. Review.

PMID:
16911191
17.

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.

Zareie M, van Lambalgen AA, ter Wee PM, Hekking LH, Keuning ED, Schadee-Eestermans IL, Faict D, Degréve B, Tangelder GJ, Beelen RH, van den Born J.

Perit Dial Int. 2005 Jan-Feb;25(1):58-67.

PMID:
15770927
18.

Advanced glycation end-products and peritoneal sclerosis.

Nakamura S, Niwa T.

Semin Nephrol. 2004 Sep;24(5):502-5. Review.

PMID:
15490420
19.

Immunopathological changes in a uraemic rat model for peritoneal dialysis.

Zareie M, De Vriese AS, Hekking LH, ter Wee PM, Schalkwijk CG, Driesprong BA, Schadee-Eestermans IL, Beelen RH, Lameire N, van den Born J.

Nephrol Dial Transplant. 2005 Jul;20(7):1350-61. Epub 2005 Apr 19.

PMID:
15840671
20.

Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.

Kim CD, Kwon HM, Park SH, Oh EJ, Kim MH, Choi SY, Choi MJ, Kim IS, Park MS, Kim YJ, Kim YL.

Ther Apher Dial. 2007 Feb;11(1):56-64.

PMID:
17309576

Supplemental Content

Support Center